When it comes to states leading the way in weight-loss injectables like Ozempic and Zepbound, the usual suspects of California and New York might come to mind. However, new data tells a different story that starts in an unexpected part of the country.
According to research by the Whitley Law Firm, West Virginia stands out as the top state for GLP-1 prescriptions per capita, with over 24,000 prescriptions filled for every 100,000 residents. This number is more than double what is seen in states with lower usage like Hawaii and Nevada. Following closely behind West Virginia are Kentucky and Louisiana, indicating a high demand for these medications in southern states.
Top 10 States with GLP-1 Prescriptions
So, what is fueling the use of GLP-1 in these less expected locations? Experts point to a combination of factors such as higher rates of obesity and type 2 diabetes, increased access through telehealth, and compounding pharmacies that make these medications more readily available.
“As discussions around GLP-1 medications evolve, it is crucial to consider the driving forces behind these trends,” says a spokesperson for the law firm. “Understanding these patterns can shape future dialogues on public health and medical accessibility.”
Meanwhile, states like California and New York, typically seen as health trendsetters, do not even make the top 10 when adjusted for population. Alaska, North Dakota, and Oklahoma are also experiencing significant growth, proving that this trend is not exclusive to Hollywood or TikTok.
In conclusion, GLP-1s are becoming prevalent everywhere, and the conversation around weight loss is no longer confined to the glamour of the red carpet. It is happening in communities large and small, in every corner of the nation.